Identifying actionable strategies: using Consolidated Framework for Implementation Research (CFIR)-informed interviews to evaluate the implementation of a multilevel intervention to improve colorectal cancer screening.

Colorectal cancer screening Consolidated Framework for Implementation Research Evidence-based intervention Federally Qualified Health Center Implementation Implementation strategy

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
31 May 2021
Historique:
received: 05 10 2020
accepted: 28 04 2021
entrez: 1 6 2021
pubmed: 2 6 2021
medline: 2 6 2021
Statut: epublish

Résumé

Many evidence-based interventions (EBIs) found to be effective in research studies often fail to translate into meaningful patient outcomes in practice. The purpose of this study was to identify facilitators and barriers that affect the implementation of three EBIs to improve colorectal cancer (CRC) screening in an urban federally qualified health center (FQHC) and offer actionable recommendations to improve future implementation efforts. We conducted 16 semi-structured interviews guided by the Consolidation Framework for Implementation Research (CFIR) to describe diverse stakeholders' implementation experience. The interviews were conducted in the participant's clinic, audio-taped, and professionally transcribed for analysis. We used the five CFIR domains and 39 constructs and subconstructs as a coding template to conduct a template analysis. Based on experiences with the implementation of three EBIs, stakeholders described barriers and facilitators related to the intervention characteristics, outer setting, and inner setting. Implementation barriers included (1) perceived burden and provider fatigue with EHR (Electronic Health Record) provider reminders, (2) unreliable and ineffectual EHR provider reminders, (3) challenges to providing health care services to diverse patient populations, (4) lack of awareness about CRC screening among patients, (5) absence of CRC screening goals, (6) poor communication on goals and performance, and (7) absence of printed materials for frontline implementers to educate patients. Implementation facilitators included (1) quarterly provider assessment and feedback reports provided real-time data to motivate change, (2) integration with workflow processes, (3) pressure from funding requirement to report quality measures, (4) peer pressure to achieve high performance, and (5) a culture of teamwork and patient-centered mentality. The CFIR can be used to conduct a post-implementation formative evaluation to identify barriers and facilitators that influenced the implementation. Furthermore, the CFIR can provide a template to organize research data and synthesize findings. With its clear terminology and meta-theoretical framework, the CFIR has the potential to promote knowledge-building for implementation. By identifying the contextual determinants, we can then determine implementation strategies to facilitate adoption and move EBIs to daily practice.

Sections du résumé

BACKGROUND BACKGROUND
Many evidence-based interventions (EBIs) found to be effective in research studies often fail to translate into meaningful patient outcomes in practice. The purpose of this study was to identify facilitators and barriers that affect the implementation of three EBIs to improve colorectal cancer (CRC) screening in an urban federally qualified health center (FQHC) and offer actionable recommendations to improve future implementation efforts.
METHODS METHODS
We conducted 16 semi-structured interviews guided by the Consolidation Framework for Implementation Research (CFIR) to describe diverse stakeholders' implementation experience. The interviews were conducted in the participant's clinic, audio-taped, and professionally transcribed for analysis.
RESULTS RESULTS
We used the five CFIR domains and 39 constructs and subconstructs as a coding template to conduct a template analysis. Based on experiences with the implementation of three EBIs, stakeholders described barriers and facilitators related to the intervention characteristics, outer setting, and inner setting. Implementation barriers included (1) perceived burden and provider fatigue with EHR (Electronic Health Record) provider reminders, (2) unreliable and ineffectual EHR provider reminders, (3) challenges to providing health care services to diverse patient populations, (4) lack of awareness about CRC screening among patients, (5) absence of CRC screening goals, (6) poor communication on goals and performance, and (7) absence of printed materials for frontline implementers to educate patients. Implementation facilitators included (1) quarterly provider assessment and feedback reports provided real-time data to motivate change, (2) integration with workflow processes, (3) pressure from funding requirement to report quality measures, (4) peer pressure to achieve high performance, and (5) a culture of teamwork and patient-centered mentality.
CONCLUSIONS CONCLUSIONS
The CFIR can be used to conduct a post-implementation formative evaluation to identify barriers and facilitators that influenced the implementation. Furthermore, the CFIR can provide a template to organize research data and synthesize findings. With its clear terminology and meta-theoretical framework, the CFIR has the potential to promote knowledge-building for implementation. By identifying the contextual determinants, we can then determine implementation strategies to facilitate adoption and move EBIs to daily practice.

Identifiants

pubmed: 34059156
doi: 10.1186/s43058-021-00150-9
pii: 10.1186/s43058-021-00150-9
pmc: PMC8167995
doi:

Types de publication

Journal Article

Langues

eng

Pagination

57

Subventions

Organisme : CDC HHS
ID : 5NU58DP006079-05-0
Pays : United States
Organisme : ACL HHS
ID : U01DP006079
Pays : United States
Organisme : NCI NIH HHS
ID : UG3 CA233229
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP006079
Pays : United States
Organisme : NCI NIH HHS
ID : UH3 CA233229
Pays : United States
Organisme : NCI NIH HHS
ID : UG3CA233229
Pays : United States

Références

Clin Gastroenterol Hepatol. 2008 Apr;6(4):443-50
pubmed: 18304882
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
J Eval Clin Pract. 2013 Oct;19(5):915-24
pubmed: 22762253
Addiction. 2017 Feb;112 Suppl 2:82-91
pubmed: 28074562
BMC Health Serv Res. 2015 Feb 14;15:62
pubmed: 25890333
Health Aff (Millwood). 2018 Nov;37(11):1736-1743
pubmed: 30395508
J Urban Health. 2005 Jun;82(2):216-24
pubmed: 15888638
BMC Fam Pract. 2012 Mar 20;13:22
pubmed: 22433118
Am J Prev Med. 2012 Jul;43(1):97-118
pubmed: 22704754
BMJ Qual Saf. 2013 Nov;22(11):899-906
pubmed: 23744537
J Gen Intern Med. 2009 Feb;24(2):211-7
pubmed: 19067085
J Am Board Fam Med. 2013 Sep-Oct;26(5):539-57
pubmed: 24004706
Fam Med. 2013 Jul-Aug;45(7):501-4
pubmed: 23846969
Cancer Epidemiol. 2009 Nov;33(5):381-6
pubmed: 19914880
NIH Consens State Sci Statements. 2010 Feb 4;27(1):1-31
pubmed: 20140035
J Behav Health Serv Res. 2016 Jan;43(1):54-70
pubmed: 25192755
Med Care Res Rev. 2004 Sep;61(3 Suppl):12S-30S
pubmed: 15375281
J Gen Intern Med. 2015 Dec;30(12):1780-7
pubmed: 25986137
Am J Prev Med. 2012 Sep;43(3):337-50
pubmed: 22898128
Implement Sci. 2014 Jul 29;9:92
pubmed: 25070404
J Clin Oncol. 2001 Sep 15;19(18 Suppl):6S-12S
pubmed: 11560964
Prev Med. 2014 Oct;67:1-5
pubmed: 24967957
AMIA Annu Symp Proc. 2012;2012:770-8
pubmed: 23304351
MMWR Recomm Rep. 2000 Mar 24;49(RR-1):15-6
pubmed: 15580727
Implement Sci. 2017 Feb 10;12(1):15
pubmed: 28187747
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Med Care. 2008 Sep;46(9 Suppl 1):S123-31
pubmed: 18725824
Implement Sci. 2010 Nov 22;5:91
pubmed: 21092164
Int J Med Inform. 2015 Feb;84(2):87-100
pubmed: 25453274
BMC Fam Pract. 2009 May 29;10:37
pubmed: 19480698
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Gen Intern Med. 2014 Jul;29 Suppl 2:S640-8
pubmed: 24715389
Implement Sci. 2014 Apr 24;9:50
pubmed: 24758164
Med Care Res Rev. 2001 Jun;58(2):194-228; discussion 229-33
pubmed: 11398646
Health Care Manage Rev. 2011 Oct-Dec;36(4):369-79
pubmed: 21691212
Am J Prev Med. 2008 Jul;35(1 Suppl):S67-74
pubmed: 18541190
J Gen Intern Med. 2014 Jul;29 Suppl 2:S572-8
pubmed: 24715401
Syst Rev. 2018 May 5;7(1):72
pubmed: 29729669
Clin Transl Sci. 2012 Feb;5(1):48-55
pubmed: 22376257
Implement Sci. 2012 Dec 03;7:117
pubmed: 23206670
Qual Res Psychol. 2015 Apr 3;12(2):202-222
pubmed: 27499705
Implement Sci. 2012 May 31;7:50
pubmed: 22651257
Implement Sci. 2014 May 08;9:55
pubmed: 24885976
Ann Fam Med. 2013 May-Jun;11 Suppl 1:S115-23
pubmed: 23690380
J Natl Med Assoc. 2008 Mar;100(3):278-84
pubmed: 18390020
Implement Sci. 2014 Oct 11;9:153
pubmed: 25304517
Implement Sci. 2016 Aug 02;11:109
pubmed: 27485452
Chest. 2017 Aug;152(2):304-311
pubmed: 28438605
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
BMC Health Serv Res. 2017 Feb 7;17(1):120
pubmed: 28173796
Soc Sci Med. 2010 Nov;71(9):1692-701
pubmed: 20850918
Implement Sci. 2013 May 10;8:51
pubmed: 23663819
Health Serv Res. 2017 Dec;52(6):2137-2155
pubmed: 27861833
Implement Sci. 2012 Mar 12;7:15
pubmed: 22409885
Health Educ Res. 2007 Feb;22(1):95-107
pubmed: 16807378
J Urban Health. 2006 Mar;83(2):231-43
pubmed: 16736372

Auteurs

Helen Lam (H)

Center for Asian Health Equity, University of Chicago, 5841 S Maryland Ave, Rm S406, MC 1140, Chicago, IL, 60637, USA. hvallina@medicine.bsd.uchicago.edu.

Michael Quinn (M)

Department of Internal Medicine Section of General Internal Medicine, University of Chicago, 5841 S Maryland Ave, Chicago, IL, 60637, USA.

Toni Cipriano-Steffens (T)

University of Chicago Medicine, 5841 S. Maryland Ave, MC 2115, Suite G109, Chicago, IL, 60637, USA.

Manasi Jayaprakash (M)

Center for Asian Health Equity, University of Chicago, 5841 S Maryland Ave, Rm S406, MC 1140, Chicago, IL, 60637, USA.

Emily Koebnick (E)

Center for Asian Health Equity, University of Chicago, 5841 S Maryland Ave, Rm S406, MC 1140, Chicago, IL, 60637, USA.

Fornessa Randal (F)

Center for Asian Health Equity, University of Chicago, 5841 S Maryland Ave, Rm S406, MC 1140, Chicago, IL, 60637, USA.

David Liebovitz (D)

Division of General Internal Medicine & Geriatrics, Feinberg School of Medicine, Northwestern University, 750 N. Lake Shore Dr., 10th Floor, Chicago, IL, 60611, USA.

Blasé Polite (B)

University of Chicago Medicine Hematology and Oncology, 5841 S Maryland Ave, Chicago, IL, 60637, USA.

Karen Kim (K)

Center for Asian Health Equity, University of Chicago, 5841 S Maryland Ave, Rm S406, MC 1140, Chicago, IL, 60637, USA.

Classifications MeSH